• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Bravida Holding AB: Bravida wins court ruling in previously communicated dispute regarding New Stavanger University Hospital

Bravida Holding

Today, 8 June 2026, the District Court of Rogaland, Norway, issued its ruling in the dispute concerning the New Stavanger University Hospital.

Bravida has received the ruling in the case relating to the New Stavanger University Hospital. The court's assessment largely finds in favour of the company. According to the ruling, Stavanger Hospital is to pay approximately NOK 330 million excluding VAT, as well as approximately NOK 150 million in interest and legal costs.

"We welcome that this dispute has now reached a ruling and that our position regarding the project has been upheld," says Mattias Johansson, CEO and Group President at Bravida.

The ruling may be subject to appeal to a higher court.

For further information, please contact:  
Liselotte Stray 
Head of Group Communications 
liselotte.stray@bravida.se 
+46 768 523 811 

Ann-Charlotte Johansson  
Interim Head of Investor Relations 
ann-charlotte.johansson@bravida.se  
+46 70 751 98 31